Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Explore the benefits of using Cash App for savings. This platform offers unique features that can help you grow your funds effectively.
24,443 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
As confirmation hearings approach, kevin warsh’s undisclosed wealth becomes a flashpoint, with a 69-page filing leavi...
The Trade Desk faced a tougher path after missing Q1 revenue and guiding for a weaker Q2, triggering multiple downgra...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
A family-run frozen-food business has turned nostalgia into a nationwide snack hit, shipping 20 million soup dumpling...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
Bank of America raises Coherent's price target to $400 on a larger AI data center market forecast, keeping a Neutral ...
Meta forced a mass internal transfer of 1,000 engineers into a new AI unit, signaling a dramatic push into generative...
Inflation soaring again, this under-the-radar ETF is quietly drawing interest from investors seeking an edge against ...
AI write-ups echo the social-media arc, but at the compute layer. Concentration of power is accelerating, with major ...
The CLARITY Act cleared the Senate Banking Committee, advancing a path toward floor consideration and a broader regul...